Replacing IV infusion sets in hospital patients weekly does not increase infection risk
Researchers hope to save significant time, money and resources in Australian hospital wards, with findings from a new University of …
Home »
DIY drug infusion that halves the risk of relapse for MS patients
DIY drug infusion that halves the risk of relapse to benefit hundreds of thousands of multiple sclerosis patients Monthly jab …
FDA Approves Genentech’s Ocrevus (ocrelizumab) Shorter 2-Hour Infusion for Relapsing and Primary Progressive Multiple Sclerosis
South San Francisco, CA — December 14, 2020 — Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: …